跳至主要内容
临床试验/IRCT20130428013151N2
IRCT20130428013151N2已完成早期 1 期

Investigating the effect of slow release mucosal drug in mouth MUCODENTOL on disease Symptoms in COVID-19 patients.

Khoram-Abad University of Medical Sciences0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
早期 1 期
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Age over 18 years old
  • Mental and physical ability to use this drug for three weeks
  • Lack of sensitivity to drugs and similar drugs
  • People are aware of time, place
  • person, are mentally and emotionally normal
  • be able to communicate verbally for telephone interviews
  • Infected to covid-19

排除标准

  • Lack of cooperation
  • Do not use the drug regularly
  • Having corona and need to be hospitalized
  • Drug sensitivity
  • Pregnancy and lactation

研究者

发起方
Khoram-Abad University of Medical Sciences

相似试验